Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Diagnostic Testing

Immunohistochemistry CD7 Test

The Immunohistochemistry CD7 Test helps identify the CD7 protein in tumor tissues, aiding in the diagnosis and management of certain cancers, particularly hematological malignancies.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tumor tissue sample, either in 10% Formal-saline or as a formalin-fixed paraffin-embedded block.
Results
Tissue biopsy reports are typically available within 5 days. Complex tissue samples may take up to 7 days. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Ensure the sample is accompanied by a copy of the histopathology report, the biopsy site information, and relevant clinical history.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry CD7 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Diagnosis of suspected T-cell leukemia or lymphoma.
  • ✓Classification of hematological malignancies.
  • ✓Evaluation of tumor tissue for CD7 protein expression.
  • ✓Guiding treatment decisions for certain cancers.
  • ✓Assisting in determining disease prognosis.
02

In plain language

What this test helps you understand

This test aids in the diagnosis and classification of certain hematological malignancies, such as T-cell leukemias and lymphomas, by identifying the presence of the CD7 protein in tumor tissue.
The Immunohistochemistry CD7 Test is a diagnostic tool used in oncology to detect the presence of the CD7 protein in tumor tissue samples. This information is valuable for diagnosing specific types of cancer, especially certain leukemias and lymphomas. Pathologists analyze the tissue to determine if CD7 is present, which can help guide treatment decisions. This test is often used when a cancer diagnosis is suspected or needs further clarification. Understanding the presence or absence of CD7 protein provides crucial details about the cancer type and its characteristics, assisting oncologists in developing appropriate treatment plans.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Ensure the sample is accompanied by a copy of the histopathology report, the biopsy site information, and relevant clinical history.
SampleTumor tissue sample, either in 10% Formal-saline or as a formalin-fixed paraffin-embedded block.
MethodologyImmunohistochemistry (IHC) using specific antibodies to detect CD7 protein expression in tissue sections.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence or absence of CD7 protein. Results must be interpreted in the context of other clinical findings, imaging, and laboratory tests. A positive or negative result alone is not diagnostic of a specific disease.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test helps identify the CD7 protein in tumor tissue, which is important for diagnosing and classifying certain types of cancer, particularly blood cancers like T-cell leukemia and lymphoma.
A tumor tissue sample is required. This can be submitted as a formalin-fixed paraffin-embedded block or in 10% Formal-saline.
Results for tissue biopsies are usually available within 5 days, but complex samples may take up to 7 days. Please confirm the current turnaround time with the laboratory.
No specific patient preparation is needed for the test itself. However, ensure the tissue sample is submitted with relevant clinical information, including the histopathology report and biopsy site.
The results indicate whether the CD7 protein was detected in the tissue sample. Your doctor will interpret these results alongside other tests and clinical information to provide a diagnosis and discuss treatment options.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Congenital Hypothyroidism Confirmatory Panel Serum Test

Confirms congenital hypothyroidism in newborns by measuring TSH and Free T4 levels. Early detection is crucial for preventing developmental delays. Available across Kenya.

Learn more →

Immunohistochemistry Single Marker With Interpretation Test

A specialized test using immunohistochemistry to detect specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.

Learn more →

Albumin Fluid Test

The Albumin Fluid Test measures albumin levels in body fluids to help diagnose infections and assess conditions affecting fluid balance. Available across Kenya.

Learn more →

Aluminium Plasma Test

Measures aluminium levels in the blood to assess potential exposure, particularly relevant for individuals in industrial settings. Confirm with the laboratory before booking.

Learn more →
Chat on WhatsApp